Drug Shortage Report for TOMUDEX
| Report ID | 222272 |
| Drug Identification Number | 02229566 |
| Brand name | TOMUDEX |
| Common or Proper name | TOMUDEX |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | RALTITREXED |
| Strength(s) | 2MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 x 2mg |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-14 |
| Estimated end date | 2024-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-24 |
| Company comments | Ordering restrictions will apply. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-24 | French | Compare |
| v4 | 2024-04-24 | English | Compare |
| v3 | 2024-03-15 | English | Compare |
| v2 | 2024-03-14 | French | Compare |
| v1 | 2024-03-14 | English | Compare |
Showing 1 to 5 of 5